Sue Gail Eckhardt sold $405K of Exelixis (EXEL)

Executed Feb 14 2025, disclosed Feb 19 2025, 5 days later.

Value, as filed

$405K

11,568 sh across 2 lots

Executed

Feb 14 2025

the trade date, as filed

Disclosed

Feb 19 2025

5 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

SE Sue Gail Eckhardt Director profile →

Sue Gail Eckhardt (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Exelixis, Inc. (EXEL). The largest single filing was $492K of EXEL (9,812 sh × $50.14, as filed), executed Jun 1.

The name

EXEL Exelixis, Inc. EXEL · Healthcare · 53 filings in 24 months ticker →

Healthcare · Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat c…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Sue Gail Eckhardt in EXEL

EXELSALE Exelixis, Inc. $492K
9,812 sh × $50.14
Exec Jun 1
Filed Jun 3 · 5:30 PM ET EXELSALE Exelixis, Inc. $169K
3,856 sh × $43.79
Exec Feb 13
Filed Feb 18 · 5:30 PM ET EXELSALE Exelixis, Inc. $805K
18,834 sh × $42.74
Exec Jun 2 2025
Filed Jun 4 2025 · 5:30 PM ET